TLIS

Talis Biomedical Corporation

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

TLIS price

Talis Biomedical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment TLIS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals TLIS

Valuation

P/E

0.00

Sector 0.84

Industry -1.42

P/BV

0.00

Sector 1.82

Industry 1.25

P/Revenue (PSR)

Sector 1.48

Industry 2.13

EV/EBITDA

0.00

Sector -43.66

Industry -35.45

EV/EBIT

0.00

Sector -47.57

Industry -38.86

P/EBITDA

Sector -31.25

Industry -21.12

P/EBIT

Sector -42.58

Industry -25.59

P/Total Assets

Sector 0.82

Industry 0.70

P/Net Current Assets

0.00

Sector -23.77

Industry -59.56

P/Working Capital

0.00

Sector -3.73

Industry -1.93

EPS

-25.52

Sector -0.70

Industry -1.22

BVPS

24.32

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

94.59%

Sector 49.32%

Industry 49.70%

EBITDA Margin

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-100.00%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-100.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.00

Sector 0.13

Industry 0.06

Profitability

ROE

-104.94%

Sector -24.30%

Industry -38.97%

ROA

-70.20%

Sector -24.50%

Industry -49.14%

ROIC

-263.73%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

7.76

Sector 1.92

Industry 2.55

Net Debt / EBITDA

0.00

Sector -23.10

Industry -8.80

Net Debt / EBIT

0.00

Sector -17.84

Industry -36.75

Net Debt / Equity

0.00

Sector -0.68

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.54

Equity/Assets

0.67

Sector 0.46

Industry 0.52

Liabilities/Assets

0.33

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

110.72%

Sector -

Industry -

5Y Earnings CAGR

-23.28%

Sector -

Industry -

Fundamentals TLIS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TLIS Talis Biomedical Corporation	$0.00	-100.00%	0.00%	0.00	0.00	-104.94%	-100.00%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%
SYK Stryker Corp.	$298.82	-19.12%	1.18%	30.25	4.70	15.55%	14.43%
PHG Koninklijke Philips NV	$25.60	-6.71%	3.91%	19.13	1.87	9.80%	6.30%
INMD InMode Ltd.	$14.09	-7.97%	0.00%	10.83	1.33	12.32%	20.69%
BDX Becton Dickinson and Company	$190.65	3.33%	2.20%	55.79	2.15	3.85%	6.29%
DXCM DexCom Inc.	$85.63	28.57%	0.00%	33.25	12.68	38.14%	20.12%
EW Edwards Lifesciences Corp.	$86.82	16.32%	0.00%	49.74	4.66	9.37%	15.43%
ALGN Align Technology Inc.	$147.89	13.37%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$28.84	-17.84%	2.68%	21.68	4.71	21.74%	9.20%
IRMD iRadimed Corporation	$88.03	21.26%	1.43%	49.39	11.19	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$94.68	-5.87%	1.02%	22.50	1.44	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TLIS - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Talis Biomedical

Talis Biomedical Corporation

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2021

Time since IPO - 5 years

136

Employees

Talis Biomedical Corporation (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $48.63 million.

The company employs approximately 136 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Talis Biomedical Corporation reported $296.00 Thousand in revenue, generating net income of $-51.03 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TLIS.

Market cap

Net worth

$48.63 million

$48,630,000.00

Assets

$72.70 million

$72,700,000.00

Total Shares Outstanding

2.00 million

2,000,000

Average Daily Trading Volume

Sector

Health

Industry

Medical Supplies and Equipment

TLIS

TLIS revenue and profits

Financial Results TLIS

DRAG THE FRAME TO SEE MORE DATA

TLIS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76